Yu (Clay) Cao | Vice President, Global Head of Drug Discovery
GenEditBio Limited

Yu (Clay) Cao, Ph.D. is the Vice President, Global Head of Drug Discovery, and U.S. Site Executive at GenEditBio. A distinguished immunologist and seasoned scientific leader, Dr. Cao brings over 15 years of experience spanning academia and the biopharmaceutical industry. He has held pivotal roles at Tessera Therapeutics, Agios Pharmaceuticals, and the Moffitt Cancer Center, where he led discovery and development programs across immuno-oncology, autoimmunity, neuroimmunology, and hematology. Dr. Cao has been a principal investigator and R&D driver from early-stage research through translational development. He is the author of more than 30 peer-reviewed publications in high-impact journals including Nature Medicine, Nature Communications, Immunity, Cancer Research, and Neuron, and is widely recognized for his contributions to the advancement of novel therapeutic strategies.